Groundbreaking cholesterol jab could revolutionise heart disease care

news • web article

Leqvio saw users achieve their target cholesterol levels faster than existing treatments

Leqvio, also known as inclisiran and developed by Novartis, had major impact on users - (PA/ALAMY) — image source: static.independent.co.uk

read more on www.independent.co.uk

1 / 1

Leqvio, also known as inclisiran and developed by Novartis, had major impact on users - (PA/ALAMY) — image source: static.independent.co.uk

❮ ❯

Related Items

The Independent

Related Lists

The best kids cartoons of all time

Best Music Ever (playlist)

Best writers of all time

The Best Keyboards